• Citer

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

par Phillips, Kelly-Anne;Aldridge, Julie R.;Ribi, Karin;Sun, Zhuoxin;Thompson, Alastair;Harvey, Vernon;Thürlimann, Beat;Cardoso, Fatima ;Pagani, Olivia;Coates, Alan;Goldhirsch, Aron;Price, Karen N.;Gelber, Richard;Bernhard, Jürg
Référence Breast cancer research and treatment, 126, 1, page (221-226)
Publication Publié, 2011-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
Auteur:	Phillips, Kelly-Anne; Aldridge, Julie R.; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan; Goldhirsch, Aron; Price, Karen N.; Gelber, Richard; Bernhard, Jürg
Informations sur la publication:	Breast cancer research and treatment, 126, 1, page (221-226)
Statut de publication:	Publié, 2011-02
Sujet CREF:	Cancérologie
Mots-clés:	Aromatase inhibitor
	Breast cancer
	Cognitive function
	Letrozole
	Quality of life
	Tamoxifen
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-010-1235-y
	info:scp/79151479469
	info:pmid/21046229